U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > NIH Global Health Funding News - Week of October 8, 2018 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

NIH Global Health Funding News - Week of October 8, 2018

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

Important news from Fogarty:

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

  • The Special Program for Research and Training in Tropical Diseases (TDR) is offering a free online course, Implementation research: infectious diseases of poverty. The step-by-step online training is for public health researchers and decision-makers, disease control program managers, academics and others that focuses on how to design and demonstrate robust IR projects to improve control of infectious diseases of poverty and generate better health outcomes. Registration is open.
    Course start date: October 13, 2018

Funding News

NIH funding news that may be relevant to global health researchers.

  • NIAID, NIDA, and ORIP Interest in Administrative Supplements to Address the Research and Resources Needed to Develop Vaccines Targeting Opioids (NOT-AI-18-055)
  • Notice of Intent to Publish the Reissuance of Drug Discovery For Nervous System Disorders PAR-16-042 (R21 Clinical Trial Not Allowed) (NOT-MH-18-055) and PAR-16-041 (R01 Clinical Trials Not Allowed) (NOT-MH-18-056)

Upcoming Deadlines